Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,324.00
Bid: 1,322.00
Ask: 1,330.00
Change: 8.00 (0.61%)
Spread: 8.00 (0.605%)
Open: 1,336.00
High: 1,338.00
Low: 1,320.00
Prev. Close: 1,316.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

3 Mar 2015 11:06

RNS Number : 3933G
First Derivatives PLC
03 March 2015
 

3 March 2015

 

First Derivatives PLC

("FD" or the "Company")

 

Result of General Meeting

Application for admission of new ordinary shares

 

FD (AIM:FDP.L, ESM:FDP.I), a leading provider of software and consulting services, announced on 12 February 2015 that the Company had placed 200,003 new ordinary shares (the "Placing Shares") conditional upon approval by shareholders at a General Meeting which was held earlier today.

 

The Company is pleased to confirm that the resolution proposed at the General Meeting was duly passed without amendment. As a result, the Placing Shares will be issued, allotted and admitted to trading on AIM and the ESM on 4 March 2015.

 

In addition, further to the announcement on 26 February 2015, FD confirms that the acquisition of Prelytix LLC was completed and that the Company has now issued and allotted 74,572 new ordinary shares (the "Consideration Shares") in respect of the initial consideration.

 

Application has been made for the Consideration Shares to be admitted to trading on AIM and the ESM and it is expected that admission will also take place on 4 March 2015. 

 

The Placing Shares and the Consideration Shares will rank pari passu with the Company's existing ordinary shares.

 

The current total issued share capital of the Company is 22,702,201 ordinary shares. Following admission of the Placing Shares and the Consideration Shares the total issued share capital of the Company will increase to 22,976,776 ordinary shares. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a charge to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company will be 22,976,776.

 

 

Enquiries:

First Derivatives plc

Brian Conlon, Chief Executive Officer

Graham Ferguson, Finance Director

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

Charles Stanley Securities

(Nominated Adviser and Broker)

Russell Cook

Carl Holmes

+44 (0)20 7149 6000

Goodbody

(ESM Adviser and Broker)

Linda Hickey

Finbarr Griffin

+353 1 667 0420

Walbrook PR

Financial PR

Sam Allen

+44 (0)20 7933 8780

 

 

About First Derivatives

FD is a global technology provider with nearly 20 years of experience of working with some of the world's largest finance, technology and energy institutions. It holds a 65% stake in Palo Alto-based Kx Systems, developer of the world-leading database technology, kdb+. It employs over 1,200 people worldwide and has operations in London, New York, Stockholm, Singapore, Hong Kong, Sydney, Toronto, Philadelphia, Dublin and its headquarters in Newry.

For further information please visit www.firstderivatives.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMPKNDKDBKDPNK
Date   Source Headline
26th Aug 20208:46 amRNSIssue of Equity
20th Aug 20206:10 pmRNSHolding(s) in Company
6th Aug 20207:00 amRNSEuronext Growth Dublin Notice
31st Jul 202012:01 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20207:00 amRNSAppointment of Kx Chief Revenue Officer
14th Jul 20207:00 amRNSDirectorate Change
9th Jul 20207:00 amRNSShare Option Plan Awards
9th Jul 20207:00 amRNSEuronext Growth Dublin Notice
8th Jul 20204:07 pmRNSResult of AGM
8th Jul 20207:00 amRNSAGM Statement
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSSenior Executive Appointment
3rd Jul 202010:23 amRNSIssue of Equity
2nd Jul 20207:00 amRNSDirectorate Change
30th Jun 20202:35 pmRNSTotal Voting Rights
9th Jun 20208:00 amRNSEuronext Growth Dublin Notice
8th Jun 20204:30 pmRNSNotice of AGM
3rd Jun 20202:33 pmRNSIssue of Equity
1st Jun 202011:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSEuronext Growth Dublin Notice
22nd May 20205:59 pmRNSIssue of Equity - Correction
21st May 20204:19 pmRNSIssue of Equity
19th May 20207:00 amRNSGlobal partnership agreement
19th May 20207:00 amRNSFull year results for the year ended 29 Feb 2020
9th Apr 20207:00 amRNSTrading Statement
31st Mar 202010:06 amRNSTotal Voting Rights
12th Mar 20207:00 amRNSEuronext Growth Dublin Notice
6th Mar 202010:52 amRNSIssue of Equity
17th Feb 20207:00 amRNSMajor oilfield services contract win
31st Jan 202012:01 pmRNSTotal Voting Rights
30th Jan 20207:00 amRNSEuronext Growth Dublin Notice
24th Jan 20202:01 pmRNSIssue of Equity
15th Jan 20207:00 amRNSCEO appointment and Board changes
31st Dec 20199:58 amRNSTotal Voting Rights
17th Dec 20197:00 amRNSEuronext Growth Dublin Notice
12th Dec 20197:00 amRNSEuronext Growth Dublin Notice
11th Dec 20193:10 pmRNSIssue of Equity
11th Dec 20197:50 amRNSHolding(s) in Company
6th Dec 20193:10 pmRNSIssue of Equity
29th Nov 20194:46 pmRNSTotal Voting Rights
15th Nov 20197:00 amRNSEuronext Growth Dublin Notice
8th Nov 20192:32 pmRNSIssue of Equity
5th Nov 20197:00 amRNSInterim results for the six months ended 31.08.19
1st Nov 201910:15 amRNSHolding(s) in Company
8th Oct 20197:00 amRNSNotice of Results
30th Sep 20191:20 pmRNSTotal Voting Rights
9th Sep 20197:00 amRNSEuronext Growth Dublin Notice
3rd Sep 20194:09 pmRNSIssue of Equity
2nd Sep 20194:35 pmRNSHolding(s) in Company
1st Aug 20198:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.